Thrombophilia Panel 1
Uncover inherited clotting risks before they affect you.
What’s tested
Pick a time
Mondays onlyThe Thrombophilia Panel 1 is a genetic screening test designed for individuals with a personal or family history of abnormal blood clotting, recurrent pregnancy loss, or unexplained thrombosis. It helps identify inherited mutations that predispose to hypercoagulability, guiding clinical management and preventive strategies. Using PCR-hybridisation, this test analyses three key genetic variants associated with thrombophilia.
Genetic Variants Screened
- Factor II (G20210A): The prothrombin gene mutation, which increases prothrombin levels and raises the risk of venous thromboembolism.
- Factor V (Leiden G1691A): The Factor V Leiden mutation, which causes resistance to activated protein C and is a common inherited clotting disorder.
- MTHFR (C677T): The methylenetetrahydrofolate reductase mutation, which can lead to elevated homocysteine levels and a modestly increased clotting risk.
Why it matters
Identifying these mutations allows for personalised risk assessment, informed family planning, and targeted prophylaxis during high-risk situations such as surgery, pregnancy, or prolonged immobility. Early detection can prevent life-threatening thrombotic events and guide appropriate clinical surveillance.
Referral required
- Identification: Photo ID (Passport or Driving Licence) is only required if you need your report for official, employment, visa/travel, premarital, or Identity-Verified Certificate (IVS) purposes (not required for personal health & wellness testing).
This test provides an official, quality-assured laboratory report with reference ranges. These results are for clinical information and do not replace your GP or consultant. Always discuss abnormal results with your GP or specialist in the context of your medical history.
WhatsApp →
